TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: The Atherosclerosis Risk in Communities (ARIC) study

Diabetologia

Volumn 51, Issue 6, 2008, Pages 968-970

  Bielinski, S J ^a   Pankow, J S ^a   Folsom, A R ^a   North, K E ^b   Boerwinkle, E ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b IL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

All cause mortality; Cardiovascular disease; Coronary heart disease; Diabetes; Peripheral artery disease; Stroke; TCF7L2; Transcription factor 7 like 2

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CONTINENTAL POPULATION GROUPS; CORONARY DISEASE; DIABETIC ANGIOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; TCF TRANSCRIPTION FACTORS;

EID: 43049135122     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-1004-1     Document Type: Article

References (14)

1. Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320-323
2. Humphries SE, Gable D, Cooper JA et al (2006) Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med 84:1-10
3. Marzi C, Huth C, Kolz M et al (2007) Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res 39:46-52
4. Helgason A, Palsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218-225
5. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL (2002) A role for the beta-catenin/T cell factor signaling cascade in vascular remodeling. Circ Res 90:340-347
6. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K (2008) Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57:645-653
7. The ARIC investigators (1989) The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129:687-702
8. Salomaa V, Matei C, Aleksic N et al (2001) Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis Risk in Communities. Atherosclerosis 157:309-314
9. Toole JF, Chambless LE, Heiss G, Tyroler HA, Paton CC (1993) Prevalence of stroke and transient ischemic attacks in the Atherosclerosis Risk in Communities (ARIC) study. Ann Epidemiol 3:500-503
10. Evenson KR, Rosamond WD, Cai J et al (1999) Physical activity and ischemic stroke risk. The atherosclerosis risk in communities study. Stroke 30:1333-1339
11. Howard G, Sharrett AR, Heiss G et al (1993) Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 24:1297-1304
12. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA (2001) White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 154:758-764
13. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M (2000) Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283:2253-2259
14. Kimber CH, Doney AS, Pearson ER et al (2007) TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia 50:1186-1191